ACCREDIT:住院期间COVID-19进展的临床评分验证。

Vinicius Lins Costa Ok Melo, Pedro Emmanuel Alvarenga Americano do Brasil PhD
{"title":"ACCREDIT:住院期间COVID-19进展的临床评分验证。","authors":"Vinicius Lins Costa Ok Melo,&nbsp;Pedro Emmanuel Alvarenga Americano do Brasil PhD","doi":"10.1016/j.gloepi.2024.100181","DOIUrl":null,"url":null,"abstract":"<div><div>COVID-19 is no longer a global health emergency, but it remains challenging to predict its prognosis.</div></div><div><h3>Objective</h3><div>To develop and validate an instrument to predict COVID-19 progression for critically ill hospitalized patients in a Brazilian population.</div></div><div><h3>Methodology</h3><div>Observational study with retrospective follow-up. Participants were consecutively enrolled for treatment in non-critical units between January 1, 2021, to February 28, 2022. They were included if they were adults, with a positive RT-PCR result, history of exposure, or clinical or radiological image findings compatible with COVID-19. The outcome was characterized as either transfer to critical care or death. Predictors such as demographic, clinical, comorbidities, laboratory, and imaging data were collected at hospitalization. A logistic model with lasso or elastic net regularization, a random forest classification model, and a random forest regression model were developed and validated to estimate the risk of disease progression.</div></div><div><h3>Results</h3><div>Out of 301 individuals, the outcome was 41.8 %. The majority of the patients in the study lacked a COVID-19 vaccination. Diabetes mellitus and systemic arterial hypertension were the most common comorbidities. After model development and cross-validation, the Random Forest regression was considered the best approach, and the following eight predictors were retained: D-dimer, Urea, Charlson comorbidity index, pulse oximetry, respiratory frequency, Lactic Dehydrogenase, RDW, and Radiologic RALE score. The model's bias-corrected intercept and slope were − 0.0004 and 1.079 respectively, the average prediction error was 0.028. The ROC AUC curve was 0.795, and the variance explained was 0.289.</div></div><div><h3>Conclusion</h3><div>The prognostic model was considered good enough to be recommended for clinical use in patients during hospitalization (<span><span>https://pedrobrasil.shinyapps.io/INDWELL/</span><svg><path></path></svg></span>). The clinical benefit and the performance in different scenarios are yet to be known.</div></div>","PeriodicalId":36311,"journal":{"name":"Global Epidemiology","volume":"9 ","pages":"Article 100181"},"PeriodicalIF":0.0000,"publicationDate":"2024-12-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11754157/pdf/","citationCount":"0","resultStr":"{\"title\":\"ACCREDIT: Validation of clinical score for progression of COVID-19 while hospitalized\",\"authors\":\"Vinicius Lins Costa Ok Melo,&nbsp;Pedro Emmanuel Alvarenga Americano do Brasil PhD\",\"doi\":\"10.1016/j.gloepi.2024.100181\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>COVID-19 is no longer a global health emergency, but it remains challenging to predict its prognosis.</div></div><div><h3>Objective</h3><div>To develop and validate an instrument to predict COVID-19 progression for critically ill hospitalized patients in a Brazilian population.</div></div><div><h3>Methodology</h3><div>Observational study with retrospective follow-up. Participants were consecutively enrolled for treatment in non-critical units between January 1, 2021, to February 28, 2022. They were included if they were adults, with a positive RT-PCR result, history of exposure, or clinical or radiological image findings compatible with COVID-19. The outcome was characterized as either transfer to critical care or death. Predictors such as demographic, clinical, comorbidities, laboratory, and imaging data were collected at hospitalization. A logistic model with lasso or elastic net regularization, a random forest classification model, and a random forest regression model were developed and validated to estimate the risk of disease progression.</div></div><div><h3>Results</h3><div>Out of 301 individuals, the outcome was 41.8 %. The majority of the patients in the study lacked a COVID-19 vaccination. Diabetes mellitus and systemic arterial hypertension were the most common comorbidities. After model development and cross-validation, the Random Forest regression was considered the best approach, and the following eight predictors were retained: D-dimer, Urea, Charlson comorbidity index, pulse oximetry, respiratory frequency, Lactic Dehydrogenase, RDW, and Radiologic RALE score. The model's bias-corrected intercept and slope were − 0.0004 and 1.079 respectively, the average prediction error was 0.028. The ROC AUC curve was 0.795, and the variance explained was 0.289.</div></div><div><h3>Conclusion</h3><div>The prognostic model was considered good enough to be recommended for clinical use in patients during hospitalization (<span><span>https://pedrobrasil.shinyapps.io/INDWELL/</span><svg><path></path></svg></span>). The clinical benefit and the performance in different scenarios are yet to be known.</div></div>\",\"PeriodicalId\":36311,\"journal\":{\"name\":\"Global Epidemiology\",\"volume\":\"9 \",\"pages\":\"Article 100181\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-12-28\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11754157/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Global Epidemiology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2590113324000476\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Global Epidemiology","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2590113324000476","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

COVID-19不再是全球突发卫生事件,但预测其预后仍然具有挑战性。目的:开发并验证一种预测巴西人群危重住院患者COVID-19进展的工具。方法:回顾性随访的观察性研究。参与者在2021年1月1日至2022年2月28日期间连续入组接受非危重病房治疗。如果他们是成年人,具有RT-PCR阳性结果、暴露史或与COVID-19相符的临床或放射图像结果,则将其纳入研究。结果要么转入重症监护,要么死亡。在住院时收集诸如人口统计学、临床、合并症、实验室和影像学数据等预测因素。采用套索或弹性网正则化的逻辑模型、随机森林分类模型和随机森林回归模型进行了开发和验证,以估计疾病进展的风险。结果:在301例患者中,有效率为41.8%。研究中的大多数患者都没有接种COVID-19疫苗。糖尿病和全身性动脉高血压是最常见的合并症。经过模型开发和交叉验证,随机森林回归被认为是最好的方法,并保留了以下八个预测指标:d -二聚体、尿素、Charlson合并症指数、脉搏血氧饱和度、呼吸频率、乳酸脱氢酶、RDW和放射学RALE评分。模型的偏置校正截距和斜率分别为- 0.0004和1.079,平均预测误差为0.028。ROC曲线为0.795,方差解释为0.289。结论:该模型预后良好,可推荐临床应用于住院患者(https://pedrobrasil.shinyapps.io/INDWELL/)。临床效益和在不同情况下的表现尚不清楚。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
ACCREDIT: Validation of clinical score for progression of COVID-19 while hospitalized
COVID-19 is no longer a global health emergency, but it remains challenging to predict its prognosis.

Objective

To develop and validate an instrument to predict COVID-19 progression for critically ill hospitalized patients in a Brazilian population.

Methodology

Observational study with retrospective follow-up. Participants were consecutively enrolled for treatment in non-critical units between January 1, 2021, to February 28, 2022. They were included if they were adults, with a positive RT-PCR result, history of exposure, or clinical or radiological image findings compatible with COVID-19. The outcome was characterized as either transfer to critical care or death. Predictors such as demographic, clinical, comorbidities, laboratory, and imaging data were collected at hospitalization. A logistic model with lasso or elastic net regularization, a random forest classification model, and a random forest regression model were developed and validated to estimate the risk of disease progression.

Results

Out of 301 individuals, the outcome was 41.8 %. The majority of the patients in the study lacked a COVID-19 vaccination. Diabetes mellitus and systemic arterial hypertension were the most common comorbidities. After model development and cross-validation, the Random Forest regression was considered the best approach, and the following eight predictors were retained: D-dimer, Urea, Charlson comorbidity index, pulse oximetry, respiratory frequency, Lactic Dehydrogenase, RDW, and Radiologic RALE score. The model's bias-corrected intercept and slope were − 0.0004 and 1.079 respectively, the average prediction error was 0.028. The ROC AUC curve was 0.795, and the variance explained was 0.289.

Conclusion

The prognostic model was considered good enough to be recommended for clinical use in patients during hospitalization (https://pedrobrasil.shinyapps.io/INDWELL/). The clinical benefit and the performance in different scenarios are yet to be known.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Global Epidemiology
Global Epidemiology Medicine-Infectious Diseases
CiteScore
5.00
自引率
0.00%
发文量
22
审稿时长
39 days
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信